Print Page  |  Close Window

VYGR

Voyager Therapeutics Inc
Common Stock

$8.79

-0.13
1.46%
Data as of: 01/15/19  4:00 p.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More